dr tyna glp 1 GLP-1s are NOT the answer! Recently, Dr. Tyna Moore and
Description
Slower gastric emptying combined with system stress impairs digestion
Aims: Individuals with lipodystrophies typically suffer from metabolic disease linked to adipose tissue dysfunction including lipoatrophic diabetes
While other GLP-1R agonists have shown promising outcomes in mitigating cancer progression, the association between some GLP-1R agonists and an increased risk of cancer remains a topic requiring more profound investigation
A Wisconsin healthcare leader explains what people should know.
This resource is designed for practitioners working with clients on GLP-1 medications
